RECRUITING

Assessing Cognitive Decline at Home

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Neuropsychiatric symptoms (NPS) refer to a range of mental and emotional issues that can be observed through how patients move, perform daily tasks, and express feelings on their faces. In this study, the investigators want to find ways to accurately and unobtrusively track these symptoms in people's homes over time. Our goals are to note when these symptoms happen, predict potential problems, and gather clear data to help doctors make accurate diagnoses. To do this, the investigators will first collect information from participants who have in-home sensors. the investigators will then use special computer programs that can recognize everyday activities and identify features that connect to scores from the Mild Behavioral Impairment Checklist (MBI-C). These scores will be compared to a questionnaire (NPIQ) filled out by caregivers or family members, along with any relevant information from doctors about the patients' symptoms. The investigators aim to see how these features can help differentiate between types of NPS, such as mood changes and agitation. Finally, the investigators will create a dashboard for doctors that summarizes the patterns of these symptoms in patients, making it easier to monitor and manage their mental health.

Official Title

Automatic Assessment of Neuropsychiatric Symptoms at Home Predictive of Mental Health and Cognitive Disorders Using Non-Intrusive Ambient Intelligence Technologies

Quick Facts

Study Start:2024-10-01
Study Completion:2026-12-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06704971

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 65+ years old
  2. * Any age and ethnicity.
  3. * With or without, or at risk of mild to moderate dementia.
  4. * Availability of a study partner (informant) who has contact with the patient at least once a week (this can also be the surrogate/LAR but does not necessarily have to be)
  1. * Those with severe mobility impairments
  2. * participants in non-home settings (skilled nursing facilities, etc.).

Contacts and Locations

Study Contact

NPS Study Team, PhD
CONTACT
650-498-0616
npsresearchstudy@stanford.edu

Principal Investigator

Ehsan Adeli, PhD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Clinical Excellence Research Center
Palo Alto, California, 94304
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Ehsan Adeli, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2026-12-30

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2026-12-30

Terms related to this study

Additional Relevant MeSH Terms

  • Mild Cognitive Impairment
  • Mild Dementia
  • Dementia Alzheimers
  • Dementia
  • Memory Impairment
  • NPS